Joseph P. Schwartz
Senior Managing Director, Rare DiseasesJoseph Schwartz is a Senior Research Analyst at Leerink Partners covering Rare Diseases.
Prior to joining the Firm in 2003, Mr. Schwartz provided economic and strategic consulting services to biotechnology and pharmaceutical companies with Charles River Associates. Earlier in his career, he held equity research positions at SG Cowen, State Street Research, and J.P. Morgan, where he analyzed the fundamental performance drivers of investments in the health care, retail, consumer, media, and entertainment sectors. Mr. Schwartz was named #1 Stock Picker for Pharmaceuticals in the 2011 FT/StarMine Analyst Awards. In 2010, he earned the Wall Street Journal’s #1 ranking for biotech stock picking as part of its “Best on the Street” analysts survey, which topped his #2 ranking in the Journal’s 2008 “Best on the Street” rankings.
Mr. Schwartz earned a B.A. in Economics from Colby College and an MBA from Babson College.
